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Improving Antimicrobial Stewardship Programs in Small Community Hospitals 
Through an Assessment and Feedback Model
Philip Chung, PharmD, MS, BCIDP1, Kate Tyner, BSN, RN, CIC1, Scott Bergman, PharmD, BCPS1,2, Terry Micheels, MSN, RN, CIC1, Mark E. Rupp, MD1,2, 
Michelle Schwedhelm, MSN, RN1, Maureen Tierney, MD, MSc3, Muhammad Salman Ashraf, MBBS1,2, Trevor Van Schooneveld, MD1,2
1Nebraska Medicine and 2University of Nebraska Medical Center, Omaha, NE; 3Nebraska Department of Health and Human Services, Healthcare-Associated Infection Team, Lincoln, NE
 ASAP performed onsite evaluation of antimicrobial stewardship efforts in 5 SCH in 
April to June 2017 using a 54-item survey based on CDC ASP core elements (CE) 
via in-person interview of ASP committee members
 Following onsite assessments, ASAP provided facility-specific recommendations 
for ASP implementation, and periodically contacted these SCH to support and 
follow progress for 12 months  
 The following ASP metrics obtained 6 to 12 months before and after onsite visits 
were compared:
 Number of ASP core elements met
 Extent of ASAP recommendations implemented
 Levofloxacin usage in days of therapy (DOT) / 1000 patient-days (PD)
 Susceptibilities of E coli to commonly tested antimicrobials
 Incidence of hospital-onset Clostridioides difficile infection (HO-CDI)
 Small community hospitals (SCH) often lack expertise and resources for 
antimicrobial stewardship program (ASP) implementation
 The CDC recommends collaboration with ASP experts in these situations
 The Nebraska Antimicrobial Stewardship Assessment and Promotion Program 
(ASAP) is a statewide initiative supported by the NE Department of Health and 
Human Services, Healthcare-Associated Infection/Antimicrobial Resistance 
Team through a CDC grant
 The mission of the program is to assist healthcare facilities in acute, long-term 
and ambulatory care settings implement ASP and other initiatives to improve 
antimicrobial use 
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DISCLOSURE
Baseline Characteristics* No. of Facilities
Bed size – median (range) 25 (10-161) beds
Average census – median (range) 7 (3-77) beds
Availability of infectious diseases/antimicrobial stewardship-trained physician 1
Availability of infectious diseases/antimicrobial stewardship-trained pharmacist 0
Formed multidisciplinary antimicrobial stewardship team 5
Team member responsible for daily antimicrobial stewardship activities
Pharmacist
Infection Preventionist
3
2
Table 1. Baseline Characteristics of Small Community Hospital Assessed (N = 5)
* Data are presented as number of facilities except bed size and average census
 Assessment and feedback by experts with infectious diseases/antimicrobial 
stewardship experience resulted in an increased number of  SCH with ASP 
meeting all 7 CDC antimicrobial stewardship core elements
 Favorable outcomes in antimicrobial use and CDI rates were also observed
 Antimicrobial susceptibilities remained unchanged but the follow-up period 
was brief
CONCLUSIONS
Table 2. Comparison of Baseline and Post-Intervention Antimicrobial Stewardship Metrics 
Parameters Baseline
Post-
Intervention
Number of facilities meeting all core elements based on simple criteria* 1 4
ASAP recommendations provided at baseline and implemented post-intervention 48 38
Levofloxacin days of therapy/1000 patient-days—mean (SD)† 114.7 (39.6) 71.1 (44.3)
Number of facilities with hospital-onset Clostridioides difficile infections 1 1
C. difficile infection/10,000 patient-days—median (range)‡ 6.6 (0.0-32.8) 0.0 (0.0-19.7)
* Using the simple criteria, a multi-component core element (Action, Tracking, Reporting, Education) is met if any subcomponent is implemented
† The 37% reduction observed was statistically significant (p = 0.04)
‡ Based on 11 months of data before and after onsite visit from the single facility with hospital-onset C. difficile infections
Figure 2. Comparison of Pre- and Post-Intervention Levofloxacin Usage
S
m
a
ll
 C
o
m
m
u
n
it
y
 
H
o
sp
it
a
ls
N
o
. 
T
es
te
d
Percent Susceptible if ≥30 Isolates or 
(Number Susceptible / Number Tested) if <30 isolates
A
m
p
ic
il
li
n
P
ip
er
a
ci
ll
in
/
T
a
zo
b
a
ct
a
m
C
ef
a
zo
li
n
C
ef
o
ta
x
im
e 
o
r 
C
ef
tr
ia
x
o
n
e
E
rt
a
p
en
em
, 
Im
ip
en
em
o
r 
M
er
o
p
en
em
C
ip
ro
fl
o
x
a
ci
n
 
o
r
L
ev
o
fl
o
x
a
ci
n
T
M
P
/S
M
X
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
1 761 913 56 56 98 99 93 90 99 93 100 100 80 68 77 73
2 137 127 52 54 99 94* 93 87 94 91 100 99 68 67 78 80
3 320 316 50* 56 95* 96* 86 89 93 94* 100 100 70 81* 71 79
4 62 86 69 57 89 88 92 85 (2/2) (2/3) 100 99 73 87 79 81
5 133 183 47 55 97 98 95 95 98 98 100 100 72 74 80 81
Table 3. Pre- and Post-Intervention Antimicrobial Susceptibilities for E coli
Abbreviation: TMP/SMX = trimethoprim/sulfamethoxazole
* Percents susceptible are based on the indicated number tested +/- 2 isolates for these antimicrobials  
Figure 1. Comparison of Pre- and Post-Intervention Core Element Implementation Using Different Criteria
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Simple Criteria, Baseline Simple Criteria, Post-Intervention Strict Criteria, Baseline Strict Criteria, Post-Intervention
Abbreviation: SCH = small community hospital
Simple criteria = core elements with multiple components (Action, Tracking, Reporting, Education) are met if any components are satisfied
Strict criteria = must satisfy 1) time-out OR prospective audit-feedback for Action; 2) track antibiotic use AND resistance for Tracking; 
3) report antibiotic use AND resistance data for Reporting; 4) educate prescribers AND staff for Education 
Abbreviation: SCH = small community hospital
Pre- and post-intervention data are based on usage from July to December 2016 and July to December 2017, respectively
 The assessment and feedback model employed to facilitate ASP implementation 
resulted in an increase in the median number of CE met from 6 to 7 (p=0.13)
 All but one facility met all 7 CE at the end of one year; the single deficient hospital 
only lacked ASP education to providers
 Of the 48 recommendations provided by ASAP, 79% were either partially or fully 
implemented by the end of one year
 Mean levofloxacin use in the 5 SCH reduced from 114.7 DOT/1000 PD in July to 
December 2016 to 71.1 DOT/1000 PD in July to December 2017 (p=0.04)
 The median incidence of CDI decreased from 6.6 to 0.0 cases/10,000 PD (p=0.74) 
in the single SCH with any HO-CDI
 Overall antimicrobial susceptibilities for E coli were unchanged before and after site 
visits for ceftriaxone/cefotaxime (93% vs. 94%), sulfamethoxazole/trimethoprim 
(76% vs. 75%) and ciprofloxacin/levofloxacin (67% vs. 68%) 
DISCUSSIONS
